Testolactone for the Treatment of Girls With LHRH Resistant Precocious Puberty
NCT00001181
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
100
Enrollment
NIH
Sponsor class
Conditions
Polyostotic Fibrous Dysplasia
Precocious Puberty
Interventions
DRUG:
Testolactone
Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)